Abstract:Despite successfully utilizing anesthetics for over 150 years, the mechanism of action remains relatively unknown. Recent studies have shown promising results, but due to the complex interactions between anesthetics and their targets, there remains a clear need for further mechanistic research. We know that lipophilicity is directly connected to anesthetic potency since lipid solubility relates to anesthetic partition into the membrane. However, clinically relevant concentrations of anesthetics do not significantly affect lipid bilayers but continue to influence various molecular targets. Lipid rafts are derived from liquid-ordered phases of the plasma membrane that contain increased concentrations of cholesterol and sphingomyelin and act as staging platforms for membrane proteins, including ion channels. Although anesthetics do not perturb membranes at clinically relevant concentrations, they have recently been shown to target lipid rafts. In this review, we summarize current research on how different types of anesthetics-local, inhalational, and intravenous-bind and affect both lipid rafts and voltage-gated sodium channels, one of their major targets, and how those effects synergize to cause anesthesia and analgesia. Local anesthetics block voltage-gated sodium channel pores while also disrupting lipid packing in ordered membranes. Inhalational anesthetics bind to the channel pore and the voltage-sensing domain while causing an increase in the number, size, and diameter of lipid rafts. Intravenous anesthetics bind to the channel primarily at the voltage-sensing domain and the selectivity filter, while causing lipid raft perturbation. These changes in lipid nanodomain structure possibly give proteins access to substrates that have translocated as a result of these structural alterations, resulting in lipid-driven anesthesia. Overall, anesthetics can impact channel activity either through direct interaction with the channel, indirectly through the lipid raft, or both. Together, these result in decreased sodium ion flux into the cell, disrupting action potentials and producing anesthetic effects. However, more research is needed to elucidate the indirect mechanisms associated with channel disruption through the lipid raft, as not much is known about anionic lipid products and their influence over voltage-gated sodium channels. Anesthetics' effect on S-palmitoylation, a promising mechanism for direct and indirect influence over voltage-gated sodium channels, is another auspicious avenue of research. Understanding the mechanisms of different types of anesthetics will allow anesthesiologists greater flexibility and more specificity when treating patients.

Molecular determinants of state-dependent block of Na+ channels by local anesthetics.

Current Concepts of the Mechanism of Action of Local Anesthetics

Characterization of Specific Roles of Sodium Channel Subtypes in Regional Anesthesia.

Anesthetic Mechanisms: Synergistic Interactions With Lipid Rafts and Voltage-Gated Sodium Channels

A pharmacological approach to the structure of sodium channels in myelinated axons

Mechanisms and Energetics of Potassium Channel Block by Local Anesthetics and Antifungal Agents.

Sodium Channels and Local Anesthetics—Old Friends With New Perspectives

The Β1 Sodium Channel Subunit Modifies the Interactions of Neurotoxins and Local Anesthetics with the Rat Brain IIA Α Sodium Channel in Isolated Membranes but Not in Intact Cells

Comparison Of Gating Properties And Use-Dependent Block Of Na(V)1.5 And Na(V)1.7 Channels By Anti-Arrhythmics Mexiletine And Lidocaine

Regulation and drug modulation of a voltage-gated sodium channel: Pivotal role of the S4–S5 linker in activation and slow inactivation

Structural basis for modulation of human Na V 1.3 by clinical drug and selective antagonist

A Potential Mechanism of Sodium Channel Mediating the General Anesthesia Induced by Propofol

Hyperpolarization-activated cyclic nucleotide-gated channels may contribute to regional anesthetic effects of lidocaine.

Structural basis for the modulation of voltage-gated sodium channels by animal toxins

Structural basis for high-voltage activation and subtype-specific inhibition of human Na<sub>v</sub>1.8

Structural basis for high-voltage activation and subtype-specific inhibition of human Na v 1.8.

Molecular determinants of drug binding and action on L-type calcium channels

Modulation of the Effects of Class-Ib Antiarrhythmics on Cardiac NaV1.5-encoded Channels by Accessory NaVβ Subunits

Molecular determinants of KCNQ1 channel block by a benzodiazepine.

Reduced Nav1.6 Sodium Channel Activity in Mice Increases In Vivo Sensitivity to Volatile Anesthetics

Structural basis for Na V 1.7 inhibition by pore blockers